Andilab, Meryll Faith .
HRN: 28-63-79 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/13/2026
METRONIDAZOLE 500MG (TAB)
03/13/2026
03/19/2026
PO
500mg
Q8
CS
Checking Initial Appropriateness
03/13/2026
CO-AMOXICLAV 625MG (TAB)
03/13/2026
03/19/2026
PO
1tab
Q8
Ltcs
Checking Initial Appropriateness
03/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/13/2026
03/14/2026
IV
500mg
Q8
Cs
Checking Initial Appropriateness